水飞蓟宾自乳化制剂对CCl4所致肝损伤的保护作用

被引:4
作者
赵艳雪 [1 ]
冯彩霞 [1 ]
刘勋涛 [2 ]
田伟 [2 ]
曹金娜 [3 ]
机构
[1] 石家庄市第五医院
[2] 石药集团中奇制药技术(石家庄)有限公司
[3] 东北制药集团股份公司
关键词
水飞蓟宾; 自乳化; 四氯化碳; 急性肝损伤;
D O I
暂无
中图分类号
R285.5 [中药实验药理];
学科分类号
100806 [中药药理学];
摘要
目的探讨水飞蓟宾自乳化制剂对CCl4所致急性肝损伤的保护作用。方法以CCl4所致小鼠急性肝损伤为模型,以生理盐水为阴性对照,以联苯双酯为阳性对照,以水飞蓟宾混悬剂为参比,以血清中谷丙转氨酶(ALT)、谷草转氨酶(AST)和肝脏中谷胱甘肽过氧化物酶(GSH-PX)活性及肝脏病理组织切片检查为指标,对比研究水飞蓟宾自乳化制剂对CCl4所致急性肝损伤的保护作用。结果水飞蓟宾自乳化制剂能显著的抑制CCl4所致的血清ALT和AST活性升高,使肝脏中的GSH-PX维持在正常水平,保护肝脏并避免其发生严重病变。结论水飞蓟宾自乳化制剂对CCl4所致急性肝损伤有保护作用。
引用
收藏
页码:1006 / 1009
页数:4
相关论文
共 9 条
[1]
Enhanced oral bioavailability of silybin by a supersaturatable self-emulsifying drug delivery system (S-SEDDS).[J].Yinghui Wei;Xiaoli Ye;Xiaoguang Shang;Xuan Peng;Qiang Bao;Minchen Liu;Manman Guo;Fanzhu Li.Colloids and Surfaces A: Physicochemical and Engineering Aspects.2011,
[2]
Enhancement of oral bioavailability of atorvastatin calcium by self-emulsifying drug delivery systems (SEDDS) [J].
Kadu, Pawan J. ;
Kushare, Sachin S. ;
Thacker, Dhaval D. ;
Gattani, Surendra G. .
PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY, 2011, 16 (01) :65-74
[3]
Early growth response-1 attenuates liver injury and promotes hepatoprotection after carbon tetrachloride exposure in mice [J].
Pritchard, Michele T. ;
Cohen, Jessica I. ;
Roychowdhury, Sanjoy ;
Pratt, Brian T. ;
Nagy, Laura E. .
JOURNAL OF HEPATOLOGY, 2010, 53 (04) :655-662
[4]
Diverse Roles of Invariant Natural Killer T Cells in Liver Injury and Fibrosis Induced by Carbon Tetrachloride [J].
Park, Ogyi ;
Jeong, Won-Il ;
Wang, Lei ;
Wang, Hua ;
Lian, Zhe-Xiong ;
Gershwin, M. Eric ;
Gao, Bin .
HEPATOLOGY, 2009, 49 (05) :1683-1694
[5]
The preparation of silybin–phospholipid complex and the study on its pharmacokinetics in rats.[J].Xiao Yanyu;Song Yunmei;Chen Zhipeng;Ping Qineng.International Journal of Pharmaceutics.2005, 1
[6]
Molecular process in acute liver injury and regeneration induced by carbon tetrachloride [J].
Taniguchi, M ;
Takeuchi, T ;
Nakatsuka, R ;
Watanabe, T ;
Sato, K .
LIFE SCIENCES, 2004, 75 (13) :1539-1549
[7]
.[J]...,
[8]
Silymarin: A review of its clinical properties in the management of hepatic disorders [J].
Wellington, K ;
Jarvis, B .
BIODRUGS, 2001, 15 (07) :465-489
[9]
SELF-EMULSIFYING DRUG DELIVERY SYSTEMS - FORMULATION AND BIOPHARMACEUTIC EVALUATION OF AN INVESTIGATIONAL LIPOPHILIC COMPOUND [J].
CHARMAN, SA ;
CHARMAN, WN ;
ROGGE, MC ;
WILSON, TD ;
DUTKO, FJ ;
POUTON, CW .
PHARMACEUTICAL RESEARCH, 1992, 9 (01) :87-93